HOME › DRUGS › PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED, PREPARED IN CELL CULTURES)
ACTIVE SUBSTANCE / INN

PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED, PREPARED IN CELL CULTURES)

Brand name(s): Incellipan
EMA LISTED
AUTHORISED
Influenza, Human
ACTIVE SUBSTANCE
Pandemic Influenza Vaccine (H5N1) (Surface Antigen, Inactivated, Adjuvanted, Prepared In Cell Cultures)
REGULATORS
EMA
SPONSORS / MAH
Seqirus Netherlands B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
IncellipanSeqirus Netherlands B.V.Authorised19/04/2024Influenza, Human

FULL INTELLIGENCE ON PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED, PREPARED IN CELL CULTURES)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →